Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cells.
Sign Up to like & getrecommendations! Published in 2020 at "Experimental hematology"
DOI: 10.1016/j.exphem.2020.01.003
Abstract: Gemcitabine (Gem), busulfan (Bu) and melphalan (Mel) are used for hematopoietic stem cell transplantation (HSCT). To further improve their efficacy, a preclinical study on their synergism with the HDAC inhibitor panobinostat (Pano) and the BCL2… read more here.
Keywords: multiple myeloma; busulfan melphalan; gemcitabine;
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13112789
Abstract: Simple Summary The lung is the most frequent site of metastasis in Ewing sarcoma, the second most common bone cancer affecting children, adolescents and young adults. The five-year overall survival of patients with isolated lung… read more here.
Keywords: sarcoma; lung metastases; busulfan melphalan; ewing sarcoma ... See more keywords